| scholarly article | Q13442814 |
| P50 | author | Ennio Tasciotti | Q38329532 |
| Francesca Taraballi | Q47110483 | ||
| Fernando Cabrera | Q61749578 | ||
| Jeffrey Van Eps | Q85321489 | ||
| P2093 | author name string | Mauro Ferrari | |
| Lewis W Francis | |||
| Bruna Corradetti | |||
| Bradley K Weiner | |||
| Silvia Minardi | |||
| Salvatore A Gazze | |||
| P2860 | cites work | Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine | Q24632756 |
| Regulation of immune responses by extracellular vesicles | Q27006748 | ||
| Materials as stem cell regulators | Q27021068 | ||
| Tissue engineering tools for modulation of the immune response | Q27023419 | ||
| Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer | Q30476541 | ||
| Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues | Q30605493 | ||
| Concentrated collagen-chondroitin sulfate scaffolds for tissue engineering applications | Q34067413 | ||
| Structure and function of aggrecan | Q34122868 | ||
| Aggrecan, an unusual polyelectrolyte: review of solution behavior and physiological implications | Q34212646 | ||
| Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate | Q34271235 | ||
| Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system | Q34335964 | ||
| The structure and function of the pericellular matrix of articular cartilage. | Q34345855 | ||
| Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need | Q35554310 | ||
| The role of macrophages in osteolysis of total joint replacement | Q35913643 | ||
| The impact of osteoarthritis: implications for research | Q35916154 | ||
| Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase | Q35927391 | ||
| Porous scaffold design for tissue engineering | Q36186499 | ||
| Foreign body reaction to biomaterials | Q36575306 | ||
| Glycosaminoglycans and proteoglycans: overlooked entities? | Q36843366 | ||
| Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. | Q36888475 | ||
| Cartilage repair: past and future--lessons for regenerative medicine. | Q37296148 | ||
| Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | Q37310621 | ||
| Strategies for articular cartilage lesion repair and functional restoration | Q37660373 | ||
| Modulation of inflammation by chondroitin sulfate | Q37732933 | ||
| Recent progress in cartilage tissue engineering | Q37870487 | ||
| Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule | Q37951364 | ||
| Chondrogenesis and cartilage tissue engineering: the longer road to technology development | Q37954480 | ||
| Scaffold-based repair for cartilage healing: a systematic review and technical note | Q38060425 | ||
| Rethinking regenerative medicine: a macrophage-centered approach | Q38269487 | ||
| The MSC curtain that stops the immune system | Q38529136 | ||
| Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis | Q39429209 | ||
| Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. | Q39682124 | ||
| The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. | Q40461728 | ||
| Tissue engineering of bone: effects of mechanical strain on osteoblastic cells in type I collagen matrices. | Q40533833 | ||
| The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System | Q42101420 | ||
| Chondroitin sulphate structure affects its immunological activities on murine splenocytes sensitized with ovalbumin | Q42156699 | ||
| Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. | Q42179070 | ||
| Using model substrates to study the dependence of focal adhesion formation on the affinity of integrin-ligand complexes. | Q42830930 | ||
| Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthr | Q43918002 | ||
| Modulation of the foreign body response to implanted sensor models through device-based delivery of the tyrosine kinase inhibitor, masitinib | Q44539819 | ||
| Mesenchymal stem cells from amnion and amniotic fluid in the bovine | Q44785526 | ||
| Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes | Q45059712 | ||
| A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow | Q46170497 | ||
| Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering | Q46413855 | ||
| Equine bone marrow mesenchymal or amniotic epithelial stem cells as feeder in a model for the in vitro culture of bovine embryos | Q48298436 | ||
| A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes. | Q50471353 | ||
| Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds. | Q50495894 | ||
| Tissue-engineered cartilage using serially passaged articular chondrocytes. Chondrocytes in alginate, combined in vivo with a synthetic (E210) or biologic biodegradable carrier (DBM). | Q50513768 | ||
| Sequential synthesis of cartilage and bone marker proteins during transdifferentiation of mouse Meckel's cartilage chondrocytes in vitro. | Q50530910 | ||
| Role of glycosaminoglycans in cellular communication. | Q51645129 | ||
| FTIR microscopic imaging of collagen and proteoglycan in bovine cartilage. | Q54025105 | ||
| Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane. | Q54346593 | ||
| Design of an artificial skin. II. Control of chemical composition | Q56621709 | ||
| Acellular collagen matrix as a possible “off the shelf” biomaterial for urethral repair | Q57395966 | ||
| Biomaterial based modulation of macrophage polarization: a review and suggested design principles | Q57879412 | ||
| Thiol–ene Mediated Neoglycosylation of Collagen Patches: A Preliminary Study | Q61773238 | ||
| Cell origin and differentiation in the repair of full-thickness defects of articular cartilage | Q70671226 | ||
| Culture of chondrocytes in alginate and collagen carrier gels | Q70879788 | ||
| Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects--a study in rabbits | Q73429613 | ||
| Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration | Q73822440 | ||
| The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease | Q74585816 | ||
| Alginate as a chondrocyte-delivery substance in combination with a non-woven scaffold for cartilage tissue engineering | Q77610377 | ||
| The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells | Q77755017 | ||
| Cellular origin of neocartilage formed at wound edges of articular cartilage in a tissue culture experiment | Q80755305 | ||
| Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells | Q83446059 | ||
| Therapeutic stem cell plasticity orchestrates tissue plasticity | Q84204656 | ||
| Mesenchymal stromal cells fail to alleviate experimental graft-versus-host disease in rats transplanted with major histocompatibility complex-mismatched bone marrow | Q84580129 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P921 | main subject | biomimetics | Q1145644 |
| cartilage development | Q5104524 | ||
| P304 | page(s) | 670-682 | |
| P577 | publication date | 2016-03-24 | |
| P1433 | published in | Stem Cells Translational Medicine | Q26842216 |
| P1476 | title | Chondroitin Sulfate Immobilized on a Biomimetic Scaffold Modulates Inflammation While Driving Chondrogenesis | |
| P478 | volume | 5 |
| Q46276610 | Akkermansia muciniphila May Determine Chondroitin Sulfate Ameliorating or Aggravating Osteoarthritis |
| Q49788067 | Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery |
| Q91372005 | Chondroitin sulfate-polydopamine modified polyethylene terephthalate with extracellular matrix-mimetic immunoregulatory functions for osseointegration |
| Q39332672 | Co-culture systems-based strategies for articular cartilage tissue engineering |
| Q47110415 | Concise Review: Biomimetic Functionalization of Biomaterials to Stimulate the Endogenous Healing Process of Cartilage and Bone Tissue |
| Q60957317 | Drug-Loaded Biomimetic Ceramics for Tissue Engineering |
| Q42363800 | Heparan Sulfate: A Potential Candidate for the Development of Biomimetic Immunomodulatory Membranes |
| Q38628097 | Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation. |
| Q61818596 | Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering |
| Q100464339 | Improving the immunosuppressive potential of articular chondroprogenitors in a three-dimensional culture setting |
| Q26744573 | Patterning Biomaterials for the Spatiotemporal Delivery of Bioactive Molecules |
| Q90483908 | Toward zonally tailored scaffolds for osteochondral differentiation of synovial mesenchymal stem cells |
Search more.